Archexin: Interim Phase IIa data

Interim data from about 9 patients with metastatic RCC in the first stage of a 2-stage, open-label Phase IIa trial showed that once-daily 125, 200 and 250 mg/m 2 IV Archexin plus Afinitor everolimus ...